Ventricular arrhythmias and sudden cardiac death
Management strategies for ventricular arrhythmias are guided by the risk of sudden death
and severity of symptoms. Patients with a substantial risk of sudden death usually need an …
and severity of symptoms. Patients with a substantial risk of sudden death usually need an …
Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial
G Hindricks, M Taborsky, M Glikson, U Heinrich… - The Lancet, 2014 - thelancet.com
Background An increasing number of patients with heart failure receive implantable
cardioverter-defibrillators (ICDs) or cardiac resynchronisation defibrillators (CRT-Ds) with …
cardioverter-defibrillators (ICDs) or cardiac resynchronisation defibrillators (CRT-Ds) with …
2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing
BL Wilkoff, L Fauchier, MK Stiles, CA Morillo… - EP …, 2016 - academic.oup.com
Implantable cardioverter-defibrillator (ICD) therapy is clearly an effective therapy for selected
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …
patients in definable populations. The benefits and risks of ICD therapy are directly impacted …
Complications arising from cardiac implantable electrophysiological devices: review of epidemiology, pathogenesis and prevention for the clinician
AR Atreya, JR Cook, PK Lindenauer - Postgraduate Medicine, 2016 - Taylor & Francis
Cardiac implantable electronic devices (CIEDs) which include devices such as permanent
pacemakers, implantable cardioverter-defibrillators and cardiac resynchronization therapy …
pacemakers, implantable cardioverter-defibrillators and cardiac resynchronization therapy …
Optimal programming of implantable cardiac-defibrillators
M Madhavan, PA Friedman - Circulation, 2013 - Am Heart Assoc
Implantable cardioverter-defibrillators (ICDs) reduce sudden cardiac death risk and improve
survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary …
survival in patients with a history of life-threatening arrhythmia or cardiac arrest (secondary …
Very high rate programming in primary prevention patients with reduced ejection fraction implanted with a defibrillator: Results from a large multicenter controlled …
N Clementy, F Challal, E Marijon, S Boveda, P Defaye… - Heart Rhythm, 2017 - Elsevier
Background Programming implantable cardioverter-defibrillators (ICDs) with a high-rate
therapy strategy has proven to be effective in reducing shocks and is associated with a …
therapy strategy has proven to be effective in reducing shocks and is associated with a …
Dynamic analysis of cardiac rhythms for discriminating atrial fibrillation from lethal ventricular arrhythmias
D DeMazumder, DE Lake, A Cheng… - Circulation …, 2013 - Am Heart Assoc
Background—Implantable cardioverter-defibrillators (ICDs), the first line of therapy for
preventing sudden cardiac death in high-risk patients, deliver appropriate shocks for …
preventing sudden cardiac death in high-risk patients, deliver appropriate shocks for …
[HTML][HTML] Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia
C Eickholt, M Siekiera, K Kirmanoglou, A Rodenbeck… - PLoS …, 2012 - journals.plos.org
Objectives The beneficial effects of cardiac resynchronization therapy (CRT) are thought to
result from favorable left ventricular (LV) reverse remodeling, however CRT is only …
result from favorable left ventricular (LV) reverse remodeling, however CRT is only …
Quantifying cardiac sympathetic denervation: first studies of 18F-fluorohydroxyphenethylguanidines in cardiomyopathy patients
DM Raffel, TC Crawford, YW Jung, RA Koeppe… - European Journal of …, 2022 - Springer
Abstract Purpose 4-18F-Fluoro-m-hydroxyphenethylguanidine (18F-4F-MHPG) and 3-18F-
fluoro-p-hydroxyphenethylguanidine (18F-3F-PHPG) were developed for quantifying …
fluoro-p-hydroxyphenethylguanidine (18F-3F-PHPG) were developed for quantifying …
The healthcare utilization and cost of treating patients experiencing inappropriate implantable cardioverter defibrillator shocks: a propensity score study
SP Bhavnani, D Giedrimiene… - Pacing and Clinical …, 2014 - Wiley Online Library
Background Inappropriate shocks (IASs) from implantable cardioverter defibrillators (ICDs)
are associated with decreased quality of life, but whether they increase healthcare utilization …
are associated with decreased quality of life, but whether they increase healthcare utilization …